BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12647510)

  • 41. The federal ban on ephedrine dietary supplements:an important event for pain practitioners and patients.
    Lipman AG
    J Pain Palliat Care Pharmacother; 2004; 18(3):1-4. PubMed ID: 15364627
    [No Abstract]   [Full Text] [Related]  

  • 42. Psychiatric effects of ephedra use: an analysis of Food and Drug Administration reports of adverse events.
    Maglione M; Miotto K; Iguchi M; Jungvig L; Morton SC; Shekelle PG
    Am J Psychiatry; 2005 Jan; 162(1):189-91. PubMed ID: 15625222
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Case of intractable ventricula fibrillation by a multicomponent dietary supplement containing ephedra and caffeine overdose].
    Takeuchi S; Homma M; Inoue J; Kato H; Murata K; Ogasawara T
    Chudoku Kenkyu; 2007 Jul; 20(3):269-71. PubMed ID: 17784561
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Beyond ephedra. Why the FDA's ban may lead users to look for other weight-loss stimulants.
    Gupta S
    Time; 2004 Jan; 163(2):78. PubMed ID: 14735657
    [No Abstract]   [Full Text] [Related]  

  • 45. Ephedra banned.
    Cockey CD
    AWHONN Lifelines; 2004; 8(1):19-25. PubMed ID: 15031882
    [No Abstract]   [Full Text] [Related]  

  • 46. Coronary thrombosis related to use of Xenadrine RFA.
    Sachdeva R; Sivasankaran S; Fishman RF; Zarich SW; McPherson CA
    Tex Heart Inst J; 2005; 32(1):74-7. PubMed ID: 15902827
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A critical evaluation of Internet marketing of products that contain ephedra.
    Ashar BH; Miller RG; Getz KJ; Pichard CP
    Mayo Clin Proc; 2003 Aug; 78(8):944-6. PubMed ID: 12911041
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dietary supplements containing ephedra alkaloids.
    Traub SJ; Hoyek W; Hoffman RS
    N Engl J Med; 2001 Apr; 344(14):1096; author reply 1096-7. PubMed ID: 11291669
    [No Abstract]   [Full Text] [Related]  

  • 49. "Tag--we're it".
    Czap A
    Altern Med Rev; 2003 May; 8(2):104. PubMed ID: 12777156
    [No Abstract]   [Full Text] [Related]  

  • 50. The FDA, regulation, and the risk of stroke.
    Fleming GA
    N Engl J Med; 2000 Dec; 343(25):1886-7. PubMed ID: 11117982
    [No Abstract]   [Full Text] [Related]  

  • 51. Adverse events associated with supplements containing ephedra alkaloids.
    Geiger JD
    Clin J Sport Med; 2002 Jul; 12(4):263. PubMed ID: 12150162
    [No Abstract]   [Full Text] [Related]  

  • 52. American Society for Clinical Pharmacology and Therapeutics position statement on the public health risks of ephedra.
    Hollister AS; Kearns GL
    Clin Pharmacol Ther; 2003 Nov; 74(5):403-5. PubMed ID: 14586380
    [No Abstract]   [Full Text] [Related]  

  • 53. Ischemic stroke after using over the counter products containing ephedra.
    Chen C; Biller J; Willing SJ; Lopez AM
    J Neurol Sci; 2004 Jan; 217(1):55-60. PubMed ID: 14675610
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A rapid and simple procedure for the determination of ephedrine alkaloids in dietary supplements by gas chromatography-mass spectrometry.
    Marchei E; Pellegrini M; Pacifici R; Zuccaro P; Pichini S
    J Pharm Biomed Anal; 2006 Aug; 41(5):1633-41. PubMed ID: 16580167
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dietary supplements containing ephedra alkaloids.
    Hutchins GM
    N Engl J Med; 2001 Apr; 344(14):1095-6; author reply 1096-7. PubMed ID: 11291668
    [No Abstract]   [Full Text] [Related]  

  • 56. [Health risks raised by ephedra in food supplements].
    van Riel AJ; de Vries I; Meulenbelt J
    Ned Tijdschr Geneeskd; 2003 Oct; 147(41):2017-9. PubMed ID: 14587144
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Seizures reported in association with use of dietary supplements.
    Haller CA; Meier KH; Olson KR
    Clin Toxicol (Phila); 2005; 43(1):23-30. PubMed ID: 15732443
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Psychiatric effects of ephedra: addiction.
    Miller SC
    Am J Psychiatry; 2005 Nov; 162(11):2198. PubMed ID: 16263877
    [No Abstract]   [Full Text] [Related]  

  • 59. Macroscopic and microscopic authentication of Chinese and North American species of Ephedra.
    Joshi VC; Khan I
    J AOAC Int; 2005; 88(3):707-13. PubMed ID: 16001843
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ephedra dangers documented.
    Health News; 2000 Dec; 6(12):6. PubMed ID: 11142943
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.